ChemicalBook >> CAS DataBase List >>None

None

CAS No.
2163056-91-3
Chemical Name:
None
Synonyms
B1-1347;BI-1347 (BI1347);BI-1347, 10 mM in DMSO;1H-Pyrazole-1-acetamide, 4-[4-(4-isoquinolinyl)phenyl]-N,N-dimethyl-;2-(4-(4-(Isoquinolin-4-yl)phenyl)-1H-pyrazol-1-yl)-N,N-dimethylacetamide;BI-1347,None,2-{4-[4-(isoquinolin-4-yl)phenyl]-1H-pyrazol-1-yl}-N,N-dimethylacetamide;BI1347,oral activity,human NK92MI cell,BI-1347,Inhibitor,CDK,mouse splenic NK cell,BI 1347,anti-tumoral activity,inhibit,Cyclin dependent kinase,selectivity
CBNumber:
CB54656561
Molecular Formula:
C22H20N4O
Molecular Weight:
356.42
MDL Number:
MFCD31716761
MOL File:
2163056-91-3.mol
MSDS File:
SDS
TDS File:
TDS
Last updated:2026-07-27 17:00:41
Product description Number Pack Size Price
BI-1347 ≥98% 43667 5mg $82
BI-1347 ≥98% 43667 10mg $156
BI-1347 ≥98% 43667 25mg $367
BI-1347 ≥98% 43667 100mg $814
BI-1347 NLD05691 5mg $389.4
More product size

None Properties

storage temp. Store at -20°C
solubility DMSO:98.0(Max Conc. mg/mL);274.95(Max Conc. mM)
Ethanol:3.0(Max Conc. mg/mL);8.42(Max Conc. mM)
form Solid
color Light yellow to yellow

SAFETY

Risk and Safety Statements

Symbol(GHS)  Exclamation Mark (GHS07)
GHS07
Signal word  Warning
Hazard statements  H302-H315-H319-H335
Precautionary statements  P261-P280-P301+P312-P302+P352-P305+P351+P338

None price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Cayman Chemical 43667 BI-1347 ≥98% 2163056-91-3 5mg $82 2026-04-30 Buy
Cayman Chemical 43667 BI-1347 ≥98% 2163056-91-3 10mg $156 2026-04-30 Buy
Cayman Chemical 43667 BI-1347 ≥98% 2163056-91-3 25mg $367 2026-04-30 Buy
Cayman Chemical 43667 BI-1347 ≥98% 2163056-91-3 100mg $814 2026-04-30 Buy
Biosynth NLD05691 BI-1347 2163056-91-3 5mg $389.4 2026-06-04 Buy
Product number Packaging Price Buy
43667 5mg $82 Buy
43667 10mg $156 Buy
43667 25mg $367 Buy
43667 100mg $814 Buy
NLD05691 5mg $389.4 Buy

None Chemical Properties,Uses,Production

Uses

BI-1347 is an orally active, selective and potent CDK8 inhibitor (IC50=1.1 nM). BI-1347 shows anti-tumoral activity[1][2].

in vivo

BI-1347 (oral gavage; 10 mg/kg; once daily; 30 d) modulates STAT1 S727 phosphorylation and shows anti-tumor activity in vivo[2].
BI-1347 (oral gavage; 10 mg/kg) intermittent schedule and BI-8382 continuous treatment combination treatment increases efficacy compared to each monotherapy in the mammary carcinoma EMT6 model[2].

Animal Model:B16-F10-luc2 syngeneic melanoma model[2]
Dosage:10 mg/kg
Administration:Oral gavage; 10 mg/kg; once daily; 30 d
Result:Reduced phosphorylation of STAT1 S727 for at least 6 h by 60%.
Showed minimal effect on body weight at 10 mg/kg.
Showed lower tumor burden both on day 23 and 29, compared to the control group.

IC 50

CDK8: 1.1 nM (IC50)

References

[1] Harald Engelhardt, et al. New phenylpyrazolylacetamide compounds and derivatives as cdk8/cdk19 inhibitors.
[2] Hofmann MH, et al. Selective and Potent CDK8/19 Inhibitors Enhance NK-Cell Activity and Promote Tumor Surveillance. Mol Cancer Ther. 2020 Apr;19(4):1018-1030. DOI:10.1158/1535-7163.MCT-19-0789

None Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 58)Suppliers
Supplier Tel Email Country ProdList Advantage
TargetMol Chemicals Inc.
+1-781-999-5354; +1-00000000000 marketing@targetmol.com United States 32431 58
BOC Sciences
16314854226; +8616314854226 inquiry@bocsci.com United States 19852 58
TargetMol Chemicals Inc.
+1-781-999-5354; support@targetmol.com United States 38999 58
Aladdin Scientific
tp@aladdinsci.com United States 54746 58
Nanjing Chemlin Chemical Co., Ltd 025-83697070 13770331960 info@chemlin.com.cn China 16305 64
Sichuan Wei Keqi Biological Technology Co., Ltd. 028-81700200 18116577057 3003855609@qq.com China 7717 56
Mashilabs (Shanghai) Co.,Ltd. 19916721580 mafarm@126.com China 4538 58
Shanghai Lollane Biological Technology Co.,Ltd. 021-52996696,15000506266 15000506266 China 4861 55
Shanghai EFE Biological Technology Co., Ltd. 021-65675885 18964387627 info@efebio.com China 9799 58
Shanghai YuanYe Biotechnology Co., Ltd. 15026964105 2881489226@qq.com China 89667 60

View Lastest Price from None manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
BI-1347 pictures 2026-07-27 BI-1347
2163056-91-3
$34.00-128.00 99.81% 10g TargetMol Chemicals Inc.
  • BI-1347 pictures
  • BI-1347
    2163056-91-3
  • $34.00-128.00
  • 99.81%
  • TargetMol Chemicals Inc.

None Spectrum

BI-1347 (BI1347) 1H-Pyrazole-1-acetamide, 4-[4-(4-isoquinolinyl)phenyl]-N,N-dimethyl- 2-(4-(4-(Isoquinolin-4-yl)phenyl)-1H-pyrazol-1-yl)-N,N-dimethylacetamide BI-1347,None,2-{4-[4-(isoquinolin-4-yl)phenyl]-1H-pyrazol-1-yl}-N,N-dimethylacetamide BI1347,oral activity,human NK92MI cell,BI-1347,Inhibitor,CDK,mouse splenic NK cell,BI 1347,anti-tumoral activity,inhibit,Cyclin dependent kinase,selectivity BI-1347, 10 mM in DMSO B1-1347 2163056-91-3